Chunlai Ma

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Real-world implications of efgartigimod in managing refractory myasthenia gravis.

Real-world implications of efgartigimod in managing refractory myasthenia gravis.

Journal: Expert opinion on biological therapy

Published: May 20, 2026

Effect moderation and heterogeneity in meta-analysis: a meta-regression-based reinterpretation of surgical site infection risk factors after craniotomy and cranioplasty.

Effect moderation and heterogeneity in meta-analysis: a meta-regression-based reinterpretation of surgical site infection risk factors after craniotomy and cranioplasty.

Journal: Journal of clinical epidemiology

Published: January 19, 2026

NDRG1 aggravates Sepsis-Induced acute lung injury via PKM2-dependent activation of STAT3 and NF-κB signaling.

NDRG1 aggravates Sepsis-Induced acute lung injury via PKM2-dependent activation of STAT3 and NF-κB signaling.

Journal: BMC immunology

Published: November 03, 2025

A Comprehensive Clinical Evaluation of Rilonacept in the Treatment of Recurrent Pericarditis: A Systematic Review.

A Comprehensive Clinical Evaluation of Rilonacept in the Treatment of Recurrent Pericarditis: A Systematic Review.

Journal: Journal of inflammation research

Published: February 24, 2025

The interplay between metabolism and neuroinflammation in epilepsy: mechanisms and therapeutic perspectives.

The interplay between metabolism and neuroinflammation in epilepsy: mechanisms and therapeutic perspectives.

Journal: Journal of neuroinflammation

Published: January 15, 2025

Comprehensive Clinical Analysis of Rilonacept in the Treatment of Cryopyrin-Associated Periodic Syndromes: A Systematic Review.

Comprehensive Clinical Analysis of Rilonacept in the Treatment of Cryopyrin-Associated Periodic Syndromes: A Systematic Review.

Journal: Journal of multidisciplinary healthcare

Published: October 14, 2024

Long-term treatment with Perampanel of Chinese patients with focal-onset seizures, especially in sleep-related epilepsy: a prospective real-world observational study.

Long-term treatment with Perampanel of Chinese patients with focal-onset seizures, especially in sleep-related epilepsy: a prospective real-world observational study.

Journal: Frontiers in neurology

Published: January 02, 2024

Treatment access and satisfaction on disease-modifying therapies of neuromyelitis optica spectrum disorder patients in China: a cross-sectional survey.

Treatment access and satisfaction on disease-modifying therapies of neuromyelitis optica spectrum disorder patients in China: a cross-sectional survey.

Journal: Therapeutic advances in neurological disorders

Published: September 10, 2023

Long way to go: Progress of orphan drug accessibility in China from 2017 to 2022.

Long way to go: Progress of orphan drug accessibility in China from 2017 to 2022.

Journal: Frontiers in pharmacology

Published: January 06, 2023

Role of pharmacists during the COVID-19 pandemic in China-Shanghai experiences.

Role of pharmacists during the COVID-19 pandemic in China-Shanghai experiences.

Journal: Journal of the American College of Clinical Pharmacy : JACCP

Published: May 29, 2020

The effects of medication education and behavioral intervention on Chinese patients with epilepsy.

The effects of medication education and behavioral intervention on Chinese patients with epilepsy.

Journal: Epilepsy & behavior : E&B

Published: March 07, 2014

Validation of Chinese version of the Morisky medication adherence scale in patients with epilepsy.

Validation of Chinese version of the Morisky medication adherence scale in patients with epilepsy.

Journal: Seizure

Published: October 18, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026